Clinical Trial Update: Electrical Coupling Information From The Rhythmia HDx System And DirectSense Technology In Subjects With Paroxysmal Atrial Fibrillation [NA]

View source ↗

Summary

Completed clinical trial evaluating electrical coupling information from Rhythmia HDx and DirectSense in paroxysmal atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Atrial Fibrillation

Drugs mentioned

• DirectSense Technology
• Rhythmia HDx System

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Paroxysmal Atrial Fibrillation | NA | Status: COMPLETED | Results posted: 2021-08-09